New Launches and Pipeline Investments Support Alcon's Market Leadership and Strong Fundamentals
Alcon is one of the leading visioncare companies in the world and operates in two segments: vision care and surgical.
Alcon is one of the leading visioncare companies in the world and operates in two segments: vision care and surgical.
Alcon is one of the leading visioncare companies in the world, with a record of successful product development, and it will continue to launch technically superior products that should lead to market outperformance.
A misstep in commercial execution for new product launches could hinder Alcon's market position and weigh down future growth rates across business units.
|
Metric
|
ALC
|
COO
|
AFX
|
|---|---|---|---|
Price/Earnings (Normalized) | 30.19 | 12.46 | 21.86 |
Price/Book Value | 1.43 | 1.31 | 1.29 |
Price/Sales | 2.89 | 2.66 | 1.22 |
Price/Cash Flow | 12.18 | 11.87 | 11.08 |
|
Metric
|
ALC
|
COO
|
AFX
|
|---|---|---|---|
Quick Ratio | 1.12 | 0.51 | 1.40 |
Current Ratio | 2.09 | 1.22 | 2.34 |
Interest Coverage | 4.19 | 6.18 | 6.98 |
|
Metric
|
ALC
|
COO
|
AFX
|
|---|---|---|---|
Return on Assets (Normalized) | 5.09% | 7.25% | — |
Return on Equity (Normalized) | 7.28% | 10.89% | — |
Return on Invested Capital (Normalized) | 6.30% | 9.02% | — |
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Intuitive Surgical Inc
ISRG
| LOCK|#&?v#^^$ | LOCK|>tH | $142B | |||
| Becton Dickinson & Co
BDX
| LOCK|@?X | LOCK|X@!? | $49B | |||
| ResMed Inc
RMD
| LOCK|ktDcdN! | LOCK|f%dG | $31B | |||
| Medline Inc Ordinary Shares - Class A
MDLN
| LOCK|tzHlm!@ | LOCK|KsPj | $31B | |||
| West Pharmaceutical Services Inc
WST
| LOCK|&BxqQGs# | LOCK|&t$ | $26B | |||
| Solventum Corp
SOLV
| LOCK|clSx#Z> | LOCK|fsN | $15B | |||
| Baxter International Inc
BAX
| LOCK|%W | LOCK|G&lsM | $12B | |||
| The Cooper Companies Inc
COO
| LOCK|^Hb@DtN | LOCK|Zxkq% | $11B | |||
| Align Technology Inc
ALGN
| LOCK|TXnX^! | LOCK|?@V^w | $10B |